This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Leishmania Antigen
Product Overview
BioVenic's Recombinant Leishmania Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Leishmania is a genus of obligate intracellular protozoan parasites transmitted by the bite of infected phlebotomine sandflies, causing visceral, cutaneous, or mucocutaneous leishmaniasis. The parasite alternates between flagellated extracellular promastigotes in the vector and non-motile intracellular amastigotes within mammalian macrophages. Key targets for diagnostics and therapeutics include lipophosphoglycan (LPG) and the surface metalloprotease gp63, which mediate macrophage binding and intracellular survival, alongside the kinetoplast DNA (kDNA) commonly used in molecular assays.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.